APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Long-acting Anti-HIV Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Long-acting Anti-HIV Drugs Industry Growth and Trends Forecast to 2032

Report ID 174008720128 December 202571 pages

Choose your research edition.

Industry ResearchLong-acting Anti-HIV Drugs Industry Research Report 2026107 pages · $2,950 USDIndustry Growth & TrendsGlobal Long-acting Anti-HIV Drugs Industry Growth and Trends Forecast to 203271 pages · $3,450 USDMarket StructureGlobal Long-acting Anti-HIV Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032170 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Long-acting Anti-HIV Drugs Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Long-acting Anti-HIV Drugs Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Long-acting Anti-HIV Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Long-acting Anti-HIV Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Long-acting Anti-HIV Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Long-acting Anti-HIV Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Long-acting Anti-HIV Drugs include Theratechnologies, ViiV Healthcare, Gilead Sciences and Janssen Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Long-acting Anti-HIV Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Long-acting Anti-HIV Drugs market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Long-acting Anti-HIV Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Long-acting Anti-HIV Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Long-acting Anti-HIV Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Long-acting Anti-HIV Drugs Market by Company

Theratechnologies

ViiV Healthcare

Gilead Sciences

Janssen Pharmaceuticals

Long-acting Anti-HIV Drugs Segment by Type

Single Drug

Combination Preparation

Long-acting Anti-HIV Drugs Segment by Application

HIV Prevention

HIV Treatment

Long-acting Anti-HIV Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Long-acting Anti-HIV Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Long-acting Anti-HIV Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Long-acting Anti-HIV Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Long-acting Anti-HIV Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Long-acting Anti-HIV Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Single Drug Table 2. Major Company of Combination Preparation Table 3. Global Long-acting Anti-HIV Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Long-acting Anti-HIV Drugs Sales by Type (2021-2026) & (K Units) Table 5. Global Long-acting Anti-HIV Drugs Sales Market Share in Volume by Type (2021-2026) Table 6. Global Long-acting Anti-HIV Drugs Sales by Type (2021-2026) & (US$ Million) Table 7. Global Long-acting Anti-HIV Drugs Sales Market Share in Value by Type (2021-2026) Table 8. Global Long-acting Anti-HIV Drugs Price by Type (2021-2026) & (US$/Unit) Table 9. Global Long-acting Anti-HIV Drugs Sales by Type (2027-2032) & (K Units) Table 10. Global Long-acting Anti-HIV Drugs Sales Market Share in Volume by Type (2027-2032) Table 11. Global Long-acting Anti-HIV Drugs Sales by Type (2027-2032) & (US$ Million) Table 12. Global Long-acting Anti-HIV Drugs Sales Market Share in Value by Type (2027-2032) Table 13. Global Long-acting Anti-HIV Drugs Price by Type (2027-2032) & (US$/Unit) Table 14. North America Long-acting Anti-HIV Drugs Sales by Type (2021-2026) & (K Units) Table 15. North America Long-acting Anti-HIV Drugs Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Long-acting Anti-HIV Drugs Sales by Type (2021-2026) & (K Units) Table 17. Europe Long-acting Anti-HIV Drugs Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Long-acting Anti-HIV Drugs Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Long-acting Anti-HIV Drugs Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Long-acting Anti-HIV Drugs Sales by Type (2021-2026) & (K Units) Table 21. Latin America Long-acting Anti-HIV Drugs Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Long-acting Anti-HIV Drugs Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Long-acting Anti-HIV Drugs Sales by Type (2021-2026) & (US$ Million) Table 24. Long-acting Anti-HIV Drugs Industry Trends Table 25. Long-acting Anti-HIV Drugs Industry Drivers Table 26. Long-acting Anti-HIV Drugs Industry Opportunities and Challenges Table 27. Long-acting Anti-HIV Drugs Industry Restraints Table 28. Global Long-acting Anti-HIV Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Long-acting Anti-HIV Drugs Revenue Market Share by Company (2021-2026) Table 30. Global Long-acting Anti-HIV Drugs Sales by Company (2021-2026) & (K Units) Table 31. Global Long-acting Anti-HIV Drugs Sales Share by Company (2021-2026) Table 32. Global Long-acting Anti-HIV Drugs Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Long-acting Anti-HIV Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Long-acting Anti-HIV Drugs Major Company Production Sites and Headquarters Table 35. Global Long-acting Anti-HIV Drugs Company, Product Type & Application Table 36. Global Long-acting Anti-HIV Drugs Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Long-acting Anti-HIV Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Long-acting Anti-HIV Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Long-acting Anti-HIV Drugs Sales by Region (2021-2026) & (K Units) Table 41. Global Long-acting Anti-HIV Drugs Sales Market Share in Volume by Region (2021-2026) Table 42. Global Long-acting Anti-HIV Drugs Sales by Region (2021-2026) & (US$ Million) Table 43. Global Long-acting Anti-HIV Drugs Sales Market Share in Value by Region (2021-2026) Table 44. Global Long-acting Anti-HIV Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Long-acting Anti-HIV Drugs Sales by Region (2027-2032) & (K Units) Table 46. Global Long-acting Anti-HIV Drugs Sales Market Share in Volume by Region (2027-2032) Table 47. Global Long-acting Anti-HIV Drugs Sales by Region (2027-2032) & (US$ Million) Table 48. Global Long-acting Anti-HIV Drugs Sales Market Share in Value by Region (2027-2032) Table 49. Global Long-acting Anti-HIV Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Long-acting Anti-HIV Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Long-acting Anti-HIV Drugs Sales by Application (2021-2026) & (K Units) Table 52. Global Long-acting Anti-HIV Drugs Sales Market Share in Volume by Application (2021-2026) Table 53. Global Long-acting Anti-HIV Drugs Sales by Application (2021-2026) & (US$ Million) Table 54. Global Long-acting Anti-HIV Drugs Sales Market Share in Value by Application (2021-2026) Table 55. Global Long-acting Anti-HIV Drugs Price by Application (2021-2026) & (US$/Unit) Table 56. Global Long-acting Anti-HIV Drugs Sales by Application (2027-2032) & (K Units) Table 57. Global Long-acting Anti-HIV Drugs Sales Market Share in Volume by Application (2027-2032) Table 58. Global Long-acting Anti-HIV Drugs Sales by Application (2027-2032) & (US$ Million) Table 59. Global Long-acting Anti-HIV Drugs Sales Market Share in Value by Application (2027-2032) Table 60. Global Long-acting Anti-HIV Drugs Price by Application (2027-2032) & (US$/Unit) Table 61. North America Long-acting Anti-HIV Drugs Sales by Application (2021-2026) & (K Units) Table 62. North America Long-acting Anti-HIV Drugs Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Long-acting Anti-HIV Drugs Sales by Application (2021-2026) & (K Units) Table 64. Europe Long-acting Anti-HIV Drugs Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Long-acting Anti-HIV Drugs Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Long-acting Anti-HIV Drugs Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Long-acting Anti-HIV Drugs Sales by Application (2021-2026) & (K Units) Table 68. Latin America Long-acting Anti-HIV Drugs Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Long-acting Anti-HIV Drugs Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Long-acting Anti-HIV Drugs Sales by Application (2021-2026) & (US$ Million) Table 71. Theratechnologies Company Information Table 72. Theratechnologies Business Overview Table 73. Theratechnologies Long-acting Anti-HIV Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Theratechnologies Long-acting Anti-HIV Drugs Product Portfolio Table 75. Theratechnologies Recent Development Table 76. ViiV Healthcare Company Information Table 77. ViiV Healthcare Business Overview Table 78. ViiV Healthcare Long-acting Anti-HIV Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. ViiV Healthcare Long-acting Anti-HIV Drugs Product Portfolio Table 80. ViiV Healthcare Recent Development Table 81. Gilead Sciences Company Information Table 82. Gilead Sciences Business Overview Table 83. Gilead Sciences Long-acting Anti-HIV Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Gilead Sciences Long-acting Anti-HIV Drugs Product Portfolio Table 85. Gilead Sciences Recent Development Table 86. Janssen Pharmaceuticals Company Information Table 87. Janssen Pharmaceuticals Business Overview Table 88. Janssen Pharmaceuticals Long-acting Anti-HIV Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Janssen Pharmaceuticals Long-acting Anti-HIV Drugs Product Portfolio Table 90. Janssen Pharmaceuticals Recent Development Table 91. North America Long-acting Anti-HIV Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 92. North America Long-acting Anti-HIV Drugs Sales by Country (2021-2026) & (K Units) Table 93. North America Long-acting Anti-HIV Drugs Sales Market Share by Country (2021-2026) Table 94. North America Long-acting Anti-HIV Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 95. North America Long-acting Anti-HIV Drugs Sales Market Share Forecast by Country (2027-2032) Table 96. North America Long-acting Anti-HIV Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 97. North America Long-acting Anti-HIV Drugs Market Size by Country (2021-2026) & (US$ Million) Table 98. North America Long-acting Anti-HIV Drugs Market Share by Country (2021-2026) Table 99. North America Long-acting Anti-HIV Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 100. North America Long-acting Anti-HIV Drugs Market Share Forecast by Country (2027-2032) Table 101. Europe Long-acting Anti-HIV Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 102. Europe Long-acting Anti-HIV Drugs Sales by Country (2021-2026) & (K Units) Table 103. Europe Long-acting Anti-HIV Drugs Sales Market Share by Country (2021-2026) Table 104. Europe Long-acting Anti-HIV Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 105. Europe Long-acting Anti-HIV Drugs Sales Market Share Forecast by Country (2027-2032) Table 106. Europe Long-acting Anti-HIV Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. Europe Long-acting Anti-HIV Drugs Market Size by Country (2021-2026) & (US$ Million) Table 108. Europe Long-acting Anti-HIV Drugs Market Share by Country (2021-2026) Table 109. Europe Long-acting Anti-HIV Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. Europe Long-acting Anti-HIV Drugs Market Share Forecast by Country (2027-2032) Table 111. Asia-Pacific Long-acting Anti-HIV Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 112. Asia-Pacific Long-acting Anti-HIV Drugs Sales by Country (2021-2026) & (K Units) Table 113. Asia-Pacific Long-acting Anti-HIV Drugs Sales Market Share by Country (2021-2026) Table 114. Asia-Pacific Long-acting Anti-HIV Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 115. Asia-Pacific Long-acting Anti-HIV Drugs Sales Market Share Forecast by Country (2027-2032) Table 116. Asia-Pacific Long-acting Anti-HIV Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Asia-Pacific Long-acting Anti-HIV Drugs Market Size by Country (2021-2026) & (US$ Million) Table 118. Asia-Pacific Long-acting Anti-HIV Drugs Market Share by Country (2021-2026) Table 119. Asia-Pacific Long-acting Anti-HIV Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Asia-Pacific Long-acting Anti-HIV Drugs Market Share Forecast by Country (2027-2032) Table 121. Latin America Long-acting Anti-HIV Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 122. Latin America Long-acting Anti-HIV Drugs Sales by Country (2021-2026) & (K Units) Table 123. Latin America Long-acting Anti-HIV Drugs Sales Market Share by Country (2021-2026) Table 124. Latin America Long-acting Anti-HIV Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 125. Latin America Long-acting Anti-HIV Drugs Sales Market Share Forecast by Country (2027-2032) Table 126. Latin America Long-acting Anti-HIV Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Latin America Long-acting Anti-HIV Drugs Market Size by Country (2021-2026) & (US$ Million) Table 128. Latin America Long-acting Anti-HIV Drugs Market Share by Country (2021-2026) Table 129. Latin America Long-acting Anti-HIV Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Latin America Long-acting Anti-HIV Drugs Market Share Forecast by Country (2027-2032) Table 131. Middle East and Africa Long-acting Anti-HIV Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. Middle East and Africa Long-acting Anti-HIV Drugs Sales by Country (2021-2026) & (K Units) Table 133. Middle East and Africa Long-acting Anti-HIV Drugs Sales Market Share by Country (2021-2026) Table 134. Middle East and Africa Long-acting Anti-HIV Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 135. Middle East and Africa Long-acting Anti-HIV Drugs Sales Market Share Forecast by Country (2027-2032) Table 136. Middle East and Africa Long-acting Anti-HIV Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Middle East and Africa Long-acting Anti-HIV Drugs Market Size by Country (2021-2026) & (US$ Million) Table 138. Middle East and Africa Long-acting Anti-HIV Drugs Market Share by Country (2021-2026) Table 139. Middle East and Africa Long-acting Anti-HIV Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Middle East and Africa Long-acting Anti-HIV Drugs Market Share Forecast by Country (2027-2032) Table 141. Key Raw Materials Table 142. Raw Materials Key Suppliers Table 143. Long-acting Anti-HIV Drugs Distributors List Table 144. Long-acting Anti-HIV Drugs Customers List Table 145. Research Programs/Design for This Report Table 146. Authors List of This Report Table 147. Secondary Sources Table 148. Primary Sources List of Figures Figure 1. Long-acting Anti-HIV Drugs Image Figure 2. Global Long-acting Anti-HIV Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Long-acting Anti-HIV Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Long-acting Anti-HIV Drugs Sales (2021-2032) & (K Units) Figure 5. Single Drug Image Figure 6. Global Single Drug Sales YoY Growth (2021-2032) & (K Units) Figure 7. Combination Preparation Image Figure 8. Global Combination Preparation Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Long-acting Anti-HIV Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Long-acting Anti-HIV Drugs Market Share by Type 2025 VS 2032 Figure 11. North America Long-acting Anti-HIV Drugs Sales Market Share in Volume by Type in 2025 Figure 12. North America Long-acting Anti-HIV Drugs Sales Market Share in Value by Type in 2025 Figure 13. Europe Long-acting Anti-HIV Drugs Sales Market Share in Volume by Type in 2025 Figure 14. Europe Long-acting Anti-HIV Drugs Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Long-acting Anti-HIV Drugs Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Long-acting Anti-HIV Drugs Sales Market Share in Value by Type in 2025 Figure 17. Latin America Long-acting Anti-HIV Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Long-acting Anti-HIV Drugs Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Long-acting Anti-HIV Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Long-acting Anti-HIV Drugs Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Long-acting Anti-HIV Drugs Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. HIV Prevention Image Figure 24. Global HIV Prevention Sales YoY Growth (2021-2032) & (K Units) Figure 25. HIV Treatment Image Figure 26. Global HIV Treatment Sales YoY Growth (2021-2032) & (K Units) Figure 27. Global Long-acting Anti-HIV Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Long-acting Anti-HIV Drugs Market Share by Application 2025 VS 2032 Figure 29. North America Long-acting Anti-HIV Drugs Sales Market Share in Volume by Application in 2025 Figure 30. North America Long-acting Anti-HIV Drugs Sales Market Share in Value by Application in 2025 Figure 31. Europe Long-acting Anti-HIV Drugs Sales Market Share in Volume by Application in 2025 Figure 32. Europe Long-acting Anti-HIV Drugs Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Long-acting Anti-HIV Drugs Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Long-acting Anti-HIV Drugs Sales Market Share in Value by Application in 2025 Figure 35. Latin America Long-acting Anti-HIV Drugs Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Long-acting Anti-HIV Drugs Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Long-acting Anti-HIV Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Long-acting Anti-HIV Drugs Sales Market Share in Value by Application in 2025 Figure 39. North America Long-acting Anti-HIV Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 40. North America Long-acting Anti-HIV Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Long-acting Anti-HIV Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Long-acting Anti-HIV Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Long-acting Anti-HIV Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. Europe Long-acting Anti-HIV Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Long-acting Anti-HIV Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Long-acting Anti-HIV Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Long-acting Anti-HIV Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Asia-Pacific Long-acting Anti-HIV Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Long-acting Anti-HIV Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Long-acting Anti-HIV Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Long-acting Anti-HIV Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Latin America Long-acting Anti-HIV Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Long-acting Anti-HIV Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Long-acting Anti-HIV Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Long-acting Anti-HIV Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Middle East and Africa Long-acting Anti-HIV Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Long-acting Anti-HIV Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Long-acting Anti-HIV Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Long-acting Anti-HIV Drugs Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Long-acting Anti-HIV Drugs Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Single Drug
  • Combination Preparation
Applications
  • HIV Prevention
  • HIV Treatment
Companies covered
  • Theratechnologies
  • ViiV Healthcare
  • Gilead Sciences
  • Janssen Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Long-acting Anti-HIV Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Long-acting Anti-HIV Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Long-acting Anti-HIV Drugs Market by Type
  6. 1.3.1 Single Drug
  7. 1.3.2 Combination Preparation
  8. 1.4 Global Long-acting Anti-HIV Drugs Market Size by Type
  9. 1.4.1 Global Long-acting Anti-HIV Drugs Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Long-acting Anti-HIV Drugs Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Long-acting Anti-HIV Drugs Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Long-acting Anti-HIV Drugs Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Long-acting Anti-HIV Drugs Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Long-acting Anti-HIV Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Long-acting Anti-HIV Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Long-acting Anti-HIV Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Long-acting Anti-HIV Drugs Industry Trends
  2. 2.2 Long-acting Anti-HIV Drugs Industry Drivers
  3. 2.3 Long-acting Anti-HIV Drugs Industry Opportunities and Challenges
  4. 2.4 Long-acting Anti-HIV Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Long-acting Anti-HIV Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Long-acting Anti-HIV Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Long-acting Anti-HIV Drugs Price (2021-2026)
  4. 3.4 Global Long-acting Anti-HIV Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Long-acting Anti-HIV Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Long-acting Anti-HIV Drugs Company, Product Type & Application
  7. 3.7 Global Long-acting Anti-HIV Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Long-acting Anti-HIV Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Long-acting Anti-HIV Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Long-acting Anti-HIV Drugs Tier 1, Tier 2, and Tier 3
4 Long-acting Anti-HIV Drugs Regional Status and Outlook
  1. 4.1 Global Long-acting Anti-HIV Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Long-acting Anti-HIV Drugs Historic Market Size by Region
  3. 4.2.1 Global Long-acting Anti-HIV Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Long-acting Anti-HIV Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Long-acting Anti-HIV Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Long-acting Anti-HIV Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Long-acting Anti-HIV Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Long-acting Anti-HIV Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Long-acting Anti-HIV Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Long-acting Anti-HIV Drugs by Application
  1. 5.1 Long-acting Anti-HIV Drugs Market by Application
  2. 5.1.1 HIV Prevention
  3. 5.1.2 HIV Treatment
  4. 5.2 Global Long-acting Anti-HIV Drugs Market Size by Application
  5. 5.2.1 Global Long-acting Anti-HIV Drugs Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Long-acting Anti-HIV Drugs Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Long-acting Anti-HIV Drugs Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Long-acting Anti-HIV Drugs Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Long-acting Anti-HIV Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Long-acting Anti-HIV Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Long-acting Anti-HIV Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Long-acting Anti-HIV Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Theratechnologies
  2. 6.1.1 Theratechnologies Company Information
  3. 6.1.2 Theratechnologies Business Overview
  4. 6.1.3 Theratechnologies Long-acting Anti-HIV Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Theratechnologies Long-acting Anti-HIV Drugs Product Portfolio
  6. 6.1.5 Theratechnologies Recent Developments
  7. 6.2 ViiV Healthcare
  8. 6.2.1 ViiV Healthcare Company Information
  9. 6.2.2 ViiV Healthcare Business Overview
  10. 6.2.3 ViiV Healthcare Long-acting Anti-HIV Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 ViiV Healthcare Long-acting Anti-HIV Drugs Product Portfolio
  12. 6.2.5 ViiV Healthcare Recent Developments
  13. 6.3 Gilead Sciences
  14. 6.3.1 Gilead Sciences Company Information
  15. 6.3.2 Gilead Sciences Business Overview
  16. 6.3.3 Gilead Sciences Long-acting Anti-HIV Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Gilead Sciences Long-acting Anti-HIV Drugs Product Portfolio
  18. 6.3.5 Gilead Sciences Recent Developments
  19. 6.4 Janssen Pharmaceuticals
  20. 6.4.1 Janssen Pharmaceuticals Company Information
  21. 6.4.2 Janssen Pharmaceuticals Business Overview
  22. 6.4.3 Janssen Pharmaceuticals Long-acting Anti-HIV Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Janssen Pharmaceuticals Long-acting Anti-HIV Drugs Product Portfolio
  24. 6.4.5 Janssen Pharmaceuticals Recent Developments
7 North America by Country
  1. 7.1 North America Long-acting Anti-HIV Drugs Sales by Country
  2. 7.1.1 North America Long-acting Anti-HIV Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Long-acting Anti-HIV Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Long-acting Anti-HIV Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Long-acting Anti-HIV Drugs Market Size by Country
  6. 7.2.1 North America Long-acting Anti-HIV Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Long-acting Anti-HIV Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Long-acting Anti-HIV Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Long-acting Anti-HIV Drugs Sales by Country
  2. 8.1.1 Europe Long-acting Anti-HIV Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Long-acting Anti-HIV Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Long-acting Anti-HIV Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Long-acting Anti-HIV Drugs Market Size by Country
  6. 8.2.1 Europe Long-acting Anti-HIV Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Long-acting Anti-HIV Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Long-acting Anti-HIV Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Long-acting Anti-HIV Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Long-acting Anti-HIV Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Long-acting Anti-HIV Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Long-acting Anti-HIV Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Long-acting Anti-HIV Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Long-acting Anti-HIV Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Long-acting Anti-HIV Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Long-acting Anti-HIV Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Long-acting Anti-HIV Drugs Sales by Country
  2. 10.1.1 South America Long-acting Anti-HIV Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Long-acting Anti-HIV Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Long-acting Anti-HIV Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Long-acting Anti-HIV Drugs Market Size by Country
  6. 10.2.1 South America Long-acting Anti-HIV Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Long-acting Anti-HIV Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Long-acting Anti-HIV Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Long-acting Anti-HIV Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Long-acting Anti-HIV Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Long-acting Anti-HIV Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Long-acting Anti-HIV Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Long-acting Anti-HIV Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Long-acting Anti-HIV Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Long-acting Anti-HIV Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Long-acting Anti-HIV Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Long-acting Anti-HIV Drugs Value Chain Analysis
  2. 12.1.1 Long-acting Anti-HIV Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Long-acting Anti-HIV Drugs Production Mode & Process
  7. 12.2 Long-acting Anti-HIV Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Long-acting Anti-HIV Drugs Distributors
  10. 12.2.3 Long-acting Anti-HIV Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst